|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Avalo Therapeutics, Inc (AVTX) |
|
|
$0.43 0.00 (0.00%) as of 4:30 Thu 7/7
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
112,320,000 |
| Market
Cap: |
48.31(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4301 - $0.4301 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
79,351 |
662,763 |
| Total Buy Value |
$0 |
$0 |
$272,578 |
$643,635 |
| Total People Bought |
0 |
0 |
3 |
4 |
| Total Buy Transactions |
0 |
0 |
18 |
32 |
| Total Shares Sold |
0 |
0 |
5,291,542 |
5,291,542 |
| Total Sell Value |
$0 |
$0 |
$3,199,077 |
$3,199,077 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
4 |
4 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
Director |
– • • |
2018-12-31 |
4 |
B |
$3.18 |
$39,081 |
D/D |
12,300 |
18,128,799 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,116,499 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-28 |
4 |
B |
$3.12 |
$82,677 |
D/D |
26,499 |
18,116,499 |
3.92 |
- |
|
| Crutcher Patrick J |
VP, Business Development |
• – – |
2018-12-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,871) |
1,634,771 |
|
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-18 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,090,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-18 |
4 |
B |
$3.31 |
$23,262 |
D/D |
7,030 |
18,090,000 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-17 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,082,970 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-17 |
4 |
B |
$3.26 |
$48,701 |
D/D |
14,938 |
18,082,970 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-14 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,068,032 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-14 |
4 |
B |
$3.33 |
$93,445 |
D/D |
28,032 |
18,068,032 |
3.92 |
- |
|
| Phillips Matthew V |
Chief Commercial Officer |
• – – |
2018-12-10 |
4 |
B |
$2.85 |
$1,415 |
D/D |
497 |
497 |
2.66 |
- |
|
| Harrell James Archie Jr |
Exec. VP, Mktg & External Comm |
• – – |
2018-12-10 |
4 |
B |
$2.85 |
$11,834 |
D/D |
4,156 |
4,156 |
2.74 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-10 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,040,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-10 |
4 |
B |
$3.36 |
$46,397 |
D/D |
13,815 |
18,040,000 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-07 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,026,185 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-07 |
4 |
B |
$3.40 |
$21,254 |
D/D |
6,185 |
18,026,185 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,020,000 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-06 |
4 |
B |
$3.44 |
$56,494 |
D/D |
16,400 |
18,020,000 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,003,600 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-04 |
4 |
B |
$3.40 |
$7,488 |
D/D |
2,200 |
18,003,600 |
3.84 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,001,400 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-03 |
4 |
B |
$3.50 |
$68,314 |
D/D |
19,495 |
18,001,400 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-11-30 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
17,981,905 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-11-30 |
4 |
B |
$3.50 |
$14,351 |
D/D |
4,102 |
17,981,905 |
3.92 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-11-29 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
17,977,803 |
1.42 |
- |
|
440 Records found
|
|
Page 9 of 18 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
